ASCO 2019 | Squamous cell lung cancer: gene targets

Paul Paik

Here, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses the development of treatments for squamous cell lung cancer and the importance of identifying new targets such as NFA202. This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics